Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

UroGen Pharma (URGN) Shares Issued: 2017-2025

Historic Shares Issued for UroGen Pharma (URGN) over the last 8 years, with Sep 2025 value amounting to $7.6 million.

  • UroGen Pharma's Shares Issued fell 49.06% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year decrease of 89.45%. This contributed to the annual value of $151.2 million for FY2024, which is 124.43% up from last year.
  • According to the latest figures from Q3 2025, UroGen Pharma's Shares Issued is $7.6 million, which was up 2,473.40% from $297,000 recorded in Q2 2025.
  • Over the past 5 years, UroGen Pharma's Shares Issued peaked at $80.1 million during Q2 2024, and registered a low of $3,000 during Q3 2021.
  • In the last 3 years, UroGen Pharma's Shares Issued had a median value of $7.6 million in 2025 and averaged $25.2 million.
  • Per our database at Business Quant, UroGen Pharma's Shares Issued surged by 55,890.21% in 2024 and then plummeted by 99.95% in 2025.
  • UroGen Pharma's Shares Issued (Quarterly) stood at $3,000 in 2021, then surged by 37,133.33% to $378,000 in 2022, then spiked by 5,857.39% to $66.5 million in 2023, then plummeted by 77.45% to $15.0 million in 2024, then tumbled by 49.06% to $7.6 million in 2025.
  • Its Shares Issued was $7.6 million in Q3 2025, compared to $297,000 in Q2 2025 and $30,000 in Q1 2025.